← Leaderboards
Richard M Weinshilboum
Mayo Clinic Coll Of Medicine, Rochester
$55,444,344
Attributed
$64,362,971
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.2M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$91,005,457 · 17
By mechanism
U19$31,698,476 · 4
U54$20,753,205 · 5
U01$17,845,627 · 2
R01$14,396,789 · 4
T32$6,290,071 · 1
P30$21,289 · 1
Top collaborators
- Saurabh Sinha23 shared
- Jun S Song23 shared
- Liewei Wang13 shared
- Jiawei Han11 shared
- Ming-Fen Ho2 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Celine M Vachon$17,209,085
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesPharmacogenomicsPharmaceutical PreparationsFundingGenomicsPharmacogeneticsBasePhenotypeResponseClinicDesignGenome-WideProgramsCommunitiesGrantClinical TrialsGenome Wide Association StudyGene ExpressionEnzymesGenotypeCell LineVariantCellsResources
Grant awards (120)
Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed Pharmacogenomics$426,787
R01 · FY2025 · AA · contact PI
Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed Pharmacogenomics$415,165
R01 · FY2024 · AA · contact PI
Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed Pharmacogenomics$569,559
R01 · FY2022 · AA · contact PI
Training Grant in Clinical Pharmacology$438,650
T32 · FY2022 · GM
Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed Pharmacogenomics$585,560
R01 · FY2021 · AA · contact PI
Training Grant in Clinical Pharmacology$481,814
T32 · FY2021 · GM
Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed Pharmacogenomics$604,737
R01 · FY2020 · AA · contact PI
Training Grant in Clinical Pharmacology$473,908
T32 · FY2020 · GM
Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed Pharmacogenomics$492,590
R01 · FY2019 · AA · contact PI
Training Grant in Clinical Pharmacology$420,332
T32 · FY2019 · GM
Inherited Variations In Drug Metabolizing Enzymes$419,836
R01 · FY2019 · GM · contact PI
Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed Pharmacogenomics$449,805
R01 · FY2018 · AA · contact PI
Inherited Variations In Drug Metabolizing Enzymes$419,836
R01 · FY2018 · GM · contact PI
Training Grant in Clinical Pharmacology$403,665
T32 · FY2018 · GM
KnowEng, a Scalable Knowledge Engine for Large-Scale Genomic Data-OVERALL$3,640,781
U54 · FY2017 · GM
DATA SCIENCE RESEARCH$3,003,221
U54 · FY2017 · GM
Inherited Variations In Drug Metabolizing Enzymes$425,123
R01 · FY2017 · GM · contact PI
ADMINISTRATIVE CORE$294,630
U54 · FY2017 · GM
Training Grant in Clinical Pharmacology$263,025
T32 · FY2017 · GM · contact PI
BD2K CONSORTIUM ACTIVITIES$194,378
U54 · FY2017 · GM
TRAINING$148,552
U54 · FY2017 · GM
Pilot for Creating Reproducible Workflows Using Docker Containers for NIH Commons$119,777
U54 · FY2017 · GM
KnowEng, a Scalable Knowledge Engine for Large-Scale Genomic Data-OVERALL$2,414,459
U54 · FY2016 · GM
DATA SCIENCE RESEARCH$2,019,482
U54 · FY2016 · GM
Inherited Variations In Drug Metabolizing Enzymes$429,300
R01 · FY2016 · GM · contact PI
Training Grant in Clinical Pharmacology$397,133
T32 · FY2016 · GM · contact PI
KnowEng, a Scalable Knowledge Engine for Large-Scale Genomic Data-OVERALL$224,176
U54 · FY2016 · GM
ADMINISTRATIVE CORE$196,719
U54 · FY2016 · GM
BD2K CONSORTIUM ACTIVITIES$99,354
U54 · FY2016 · GM
TRAINING$98,904
U54 · FY2016 · GM
KnowEng, a Scalable Knowledge Engine for Large-Scale Genomic Data-OVERALL$2,281,452
U54 · FY2015 · GM
DATA SCIENCE RESEARCH$1,874,629
U54 · FY2015 · GM
KnowEng, a Scalable Knowledge Engine for Large-Scale Genomic Data-OVERALL$489,338
U54 · FY2015 · GM
Training Grant in Clinical Pharmacology$384,070
T32 · FY2015 · GM · contact PI
Inherited Variations In Drug Metabolizing Enzymes$353,032
R01 · FY2015 · GM · contact PI
ADMINISTRATIVE CORE$188,005
U54 · FY2015 · GM
BD2K CONSORTIUM ACTIVITIES$124,032
U54 · FY2015 · GM
TRAINING$94,786
U54 · FY2015 · GM
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$3,141,483
U19 · FY2014 · GM · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$2,023,207
U19 · FY2014 · GM · contact PI
KnowEng, a Scalable Knowledge Engine for Large-Scale Genomic Data-OVERALL$1,623,265
U54 · FY2014 · GM
DATA SCIENCE RESEARCH$1,352,683
U54 · FY2014 · GM
PGRN PHARMACOGENOMIC ONTOLOGY NETWORK RESOURCE$643,966
U19 · FY2014 · GM · contact PI
NEXT GENERATION DNA SEQUENCING NETWORK RESOURCE$474,310
U19 · FY2014 · GM · contact PI
Inherited Variations In Drug Metabolizing Enzymes$353,032
R01 · FY2014 · GM · contact PI
Training Grant in Clinical Pharmacology$317,548
T32 · FY2014 · GM · contact PI
ADMINISTRATIVE CORE$131,933
U54 · FY2014 · GM
BD2K CONSORTIUM ACTIVITIES$72,133
U54 · FY2014 · GM
TRAINING$66,516
U54 · FY2014 · GM
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$3,058,214
U19 · FY2013 · GM · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$1,985,438
U19 · FY2013 · GM · contact PI
PGRN PHARMACOGENOMIC ONTOLOGY NETWORK RESOURCE$611,196
U19 · FY2013 · GM · contact PI
NEXT GENERATION DNA SEQUENCING NETWORK RESOURCE$461,580
U19 · FY2013 · GM · contact PI
Inherited Variations In Drug Metabolizing Enzymes$336,976
R01 · FY2013 · GM · contact PI
Training Grant in Clinical Pharmacology$293,987
T32 · FY2013 · GM · contact PI
Pharmacogenomics of cytosine arabinoside (Ara-C) and acute myelogenous leukemia$233,485
R01 · FY2013 · CA · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$3,120,485
U19 · FY2012 · GM · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$2,086,208
U19 · FY2012 · GM · contact PI
PGRN PHARMACOGENOMIC ONTOLOGY NETWORK RESOURCE$551,890
U19 · FY2012 · GM · contact PI
NEXT GENERATION DNA SEQUENCING NETWORK RESOURCE$482,387
U19 · FY2012 · GM · contact PI
Inherited Variations In Drug Metabolizing Enzymes$363,948
R01 · FY2012 · GM · contact PI
Training Grant in Clinical Pharmacology$165,539
T32 · FY2012 · GM · contact PI
Pharmacogenomics of cytosine arabinoside (Ara-C) and acute myelogenous leukemia$1
R01 · FY2012 · CA · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$3,225,056
U19 · FY2011 · GM · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$2,126,969
U19 · FY2011 · GM · contact PI
Pharmacogenomics of Breast Cancer Adjuvant Chemotherapy$777,588
U01 · FY2011 · HG · contact PI
PGRN PHARMACOGENOMIC ONTOLOGY NETWORK RESOURCE$612,317
U19 · FY2011 · GM · contact PI
NEXT GENERATION DNA SEQUENCING NETWORK RESOURCE$485,770
U19 · FY2011 · GM · contact PI
Pharmacogenomics of cytosine arabinoside (Ara-C) and acute myelogenous leukemia$327,333
R01 · FY2011 · CA · contact PI
Training Grant in Clinical Pharmacology$282,556
T32 · FY2011 · GM · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$3,304,000
U19 · FY2010 · GM · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$2,222,489
U19 · FY2010 · GM · contact PI
Pharmacogenomics of Breast Cancer Adjuvant Chemotherapy$814,228
U01 · FY2010 · HG · contact PI
PGRN PHARMACOGENOMIC ONTOLOGY NETWORK RESOURCE$562,474
U19 · FY2010 · GM · contact PI
NEXT GENERATION DNA SEQUENCING NETWORK RESOURCE$519,037
U19 · FY2010 · GM · contact PI
Inherited Variations in Drug Metabolizing Enzymes$382,413
R01 · FY2010 · GM · contact PI
Pharmacogenomics of cytosine arabinoside (Ara-C) and acute myelogenous leukemia$339,262
R01 · FY2010 · CA · contact PI
Training Grant in Clinical Pharmacology$295,529
T32 · FY2010 · GM · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$2,396,902
U01 · FY2009 · GM · contact PI
Pharmacogenomics of Breast Cancer Adjuvant Chemotherapy$522,217
U01 · FY2009 · HG · contact PI
Inherited Variations in Drug Metabolizing Enzymes$378,312
R01 · FY2009 · GM · contact PI
Pharmacogenomics of cytosine arabinoside (Ara-C) and acute myelogenous leukemia$361,910
R01 · FY2009 · CA · contact PI
Training Grant in Clinical Pharmacology$228,385
T32 · FY2009 · GM · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$2,136,329
U01 · FY2008 · GM · contact PI
Inherited Variations in Drug Metabolizing Enzymes$370,579
R01 · FY2008 · GM · contact PI
Pharmacogenomics of cytosine arabinoside (Ara-C) and acute myelogenous leukemia$364,502
R01 · FY2008 · CA · contact PI
Training Grant in Clinical Pharmacology$218,821
T32 · FY2008 · GM · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$19,367
U01 · FY2008 · GM · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$2,520,713
U01 · FY2007 · GM · contact PI
Inherited Variations in Drug Metabolizing Enzymes$405,801
R01 · FY2007 · GM · contact PI
Sulfate Conjugation and Drug Metabolism$328,664
R01 · FY2007 · GM · contact PI
Training Grant in Clinical Pharmacology$205,853
T32 · FY2007 · GM · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$2,586,629
U01 · FY2006 · GM · contact PI
Inherited Variations In Drug Metabolizing Enzymes$339,856
R01 · FY2006 · GM · contact PI
Sulfate Conjugation and Drug Metabolism$338,480
R01 · FY2006 · GM · contact PI
Training Grant in Clinical Pharmacology$264,100
T32 · FY2006 · GM · contact PI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$2,660,531
U01 · FY2005 · GM
Inherited Variations In Drug Metabolizing Enzymes$347,194
R01 · FY2005 · GM
Sulfate Conjugation and Drug Metabolism$346,625
R01 · FY2005 · GM
Training Grant in Clinical Pharmacology$262,000
T32 · FY2005 · GM
PHARMACOGENETICS OF PHASE II DRUG METABOLIZING ENZYMES$572,852
U01 · FY2004 · GM
Inherited Variations In Drug Metabolizing Enzymes$345,030
R01 · FY2004 · GM
Sulfate Conjugation and Drug Metabolism$339,319
R01 · FY2004 · GM
Training Grant in Clinical Pharmacology$261,741
T32 · FY2004 · GM
STAFF INVESTIGATOR$21,289
P30 · FY2004 · CA
PHARMACOGENETICS OF PHASE II DRUG METABOLIZING ENZYMES$556,167
U01 · FY2003 · GM
Inherited Variations In Drug Metabolizing Enzymes$361,400
R01 · FY2003 · GM
Training Grant in Clinical Pharmacology$231,415
T32 · FY2003 · GM
PHARMACOGENETICS OF PHASE II DRUG METABOLIZING ENZYMES$121,329
U01 · FY2003 · GM
SULFATE CONJUGATION AND DRUG METABOLISM$97,451
R01 · FY2003 · GM
PHARMACOGENETICS OF PHASE II DRUG METABOLIZING ENZYMES$540,901
U01 · FY2002 · GM
PHARMACOGENETICS OF PHASE II DRUG METABOLIZING ENZYMES$517,712
U01 · FY2002 · GM
INHERITED VARIATIONS IN DRUG METABOLIZING ENZYMES$304,973
R01 · FY2002 · GM
SULFATE CONJUGATION AND DRUG METABOLISM$289,520
R01 · FY2002 · GM
PHARMACOGENETICS OF PHASE II DRUG METABOLIZING ENZYMES$526,080
U01 · FY2001 · GM
INHERITED VARIATIONS IN DRUG METABOLIZING ENZYMES$298,133
R01 · FY2001 · GM
SULFATE CONJUGATION AND DRUG METABOLISM$283,033
R01 · FY2001 · GM
PHARMACOGENETICS OF PHASE II DRUG METABOLIZING ENZYMES$576,082
U01 · FY2000 · GM
INHERITED VARIATIONS IN DRUG METABOLIZING ENZYMES$291,493
R01 · FY2000 · GM
SULFATE CONJUGATION AND DRUG METABOLISM$276,734
R01 · FY2000 · GM